Patrice Jichlinski

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


262 publications

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | ...
Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential.
Derré L., Lucca I., Cesson V., Bohner P., Crettenand F., Rodrigues-Dias S.C., Dartiguenave F., Masnada A., Teixeira-Pereira C., Benmerzoug S. et al., 2023/12/14. Journal for immunotherapy of cancer, 11 (12) pp. e008020. Peer-reviewed.
Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study.
Cloitre M., Valerio M., Mampuya A., Rakauskas A., Berthold D., Tawadros T., Meuwly J.Y., Heym L., Duclos F., Vallet V. et al., 2023/04/01. The British journal of radiology, 96 (1145) p. 20220803. Peer-reviewed.
Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies.
Domingos-Pereira S., Sathiyanadan K., Polak L., Haefliger J.A., Schmittnaegel M., Ries C.H., Jichlinski P., Roth B., Derré L., Nardelli-Haefliger D., 2022/12/21. International journal of molecular sciences, 24 (1) p. 123. Peer-reviewed.
Intravesical Ty21a Treatment of Non-muscle-invasive Bladder Cancer Shows a Good Safety Profile.
Lucca I., Derré L., Cesson V., Bohner P., Crettenand F., Rodrigues-Dias S., Dartiguenave F., Masnada A., Texeira-Pereira C., Benmerzoug S. et al., 2022/11. European urology open science, 45 pp. 55-58. Peer-reviewed.
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.
Nguyen S., Chevalier M.F., Benmerzoug S., Cesson V., Schneider A.K., Rodrigues-Dias S.C., Dartiguenave F., Lucca I., Jichlinski P., Roth B. et al., 2022/08. Journal for immunotherapy of cancer, 10 (8) pp. e004880. Peer-reviewed.
 
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.
Benmerzoug S., Chevalier M.F., Verardo M., Nguyen S., Cesson V., Schneider A.K., Dartiguenave F., Rodrigues-Dias S.C., Lucca I., Jichlinski P. et al., 2022/05. European urology focus, 8 (3) pp. 748-751. Peer-reviewed.
Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer Patients.
Benmerzoug S., Chevalier M.F., Villier L., Nguyen S., Cesson V., Schneider A.K., Dartiguenave F., Rodrigues-Dias S.C., Lucca I., Jichlinski P. et al., 2021/12. European urology open science, 34 pp. 79-82. Peer-reviewed.
Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study.
Rakauskas A., Tawadros T., Lucca I., Herrera F., Bourhis J., Burruni R., Gomes M.N., Codeluppi C., Jolliet L., La Rosa S. et al., 2021/07. Investigative and clinical urology, 62 (4) pp. 416-422. Peer-reviewed.
 
The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy.
Perrin A., Venderink W., Patak M.A., Möckel C., Fehr J.L., Jichlinski P., Porcellini B., Lucca I., Futterer J., Valerio M., 2021/05. Urologic oncology, 39 (5) pp. 297.e9-297.e16. Peer-reviewed.
 
The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer.
Bacchetta F., Martins M., Regusci S., Jichlinski P., Meuwly J.Y., Lucca I., Valerio M., 2020/11. Urologic oncology, 38 (11) pp. 846.e1-846.e7. Peer-reviewed.
 
Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.
Mastelic-Gavillet B., Sarivalasis A., Lozano L.E., Wyss T., Inoges S., de Vries IJM, Dartiguenave F., Jichlinski P., Derrè L., Coukos G. et al., 2020/06/23. European journal of cancer, 135 pp. 173-182. Peer-reviewed.
 
Intramuscular Immunization Induces Antigen-specific Antibodies in Urine.
Derré L., Lucca I., Cesson V., Valerio M., Cerantola Y., Burruni R., Fritschi U., Gharbi D., Bobst M., Legris A.S. et al., 2020/03/15. European urology focus, 6 (2) pp. 280-283. Peer-reviewed.
 
Reduction and follow-up of hospital discharge letter delay using Little's law.
Burruni R., Cuany B., Valerio M., Jichlinski P., Kulik G., 2019/12/31. International journal for quality in health care, 31 (10) pp. 787-792. Peer-reviewed.
Actualité du traitement chirurgical de l’incontinence urinaire d’effort chez la femme [Current surgical treatments for women with stress urinary incontinence]
Zbinden M., Stritt K., Jichlinski P., Grilo N., 2019/11/27. Revue medicale suisse, 15 (673) pp. 2186-2189. Peer-reviewed.
Coût de la prise en charge du cancer : l’investissement en urologie est-il raisonnable ?
Iselin C., Jichlinski P., 2019/11/27. Revue medicale suisse, 15 (673) pp. 2183-2184. Peer-reviewed.
Prise en charge de cancers urologiques chez la population âgée : quels enjeux ? [Management of urologic cancers in elderly people : which implications ?]
Schaer S., Valerio M., Jichlinski P., Lucca I., 2019/11/27. Revue medicale suisse, 15 (673) pp. 2195-2197. Peer-reviewed.
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8<sup>+</sup> T cells.
Mastelic-Gavillet B., Navarro Rodrigo B., Décombaz L., Wang H., Ercolano G., Ahmed R., Lozano L.E., Ianaro A., Derré L., Valerio M. et al., 2019/10/10. Journal for immunotherapy of cancer, 7 (1) p. 257. Peer-reviewed.
Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell-Mediated Tumor Regression in the MB49 Bladder Cancer Model.
Domingos-Pereira S., Sathiyanadan K., La Rosa S., Polák L., Chevalier M.F., Martel P., Hojeij R., Derré L., Haefliger J.A., Jichlinski P. et al., 2019/04. Cancer immunology research, 7 (4) pp. 621-629. Peer-reviewed.
50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
Herrera F.G., Valerio M., Berthold D., Tawadros T., Meuwly J.Y., Vallet V., Baumgartner P., Thierry A.C., De Bari B., Jichlinski P. et al., 2019/02/01. International journal of radiation oncology, biology, physics, 103 (2) pp. 320-334. Peer-reviewed.
 
Urologie [Urology in 2018]
Jichlinski P., 2019/01/16. Revue medicale suisse, 15 (634) pp. 167-169. Peer-reviewed.
Double Positive CD4<sup>+</sup>CD8<sup>+</sup> T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization.
Bohner P., Chevalier M.F., Cesson V., Rodrigues-Dias S.C., Dartiguenave F., Burruni R., Tawadros T., Valerio M., Lucca I., Nardelli-Haefliger D. et al., 2019. Frontiers in immunology, 10 p. 622. Peer-reviewed.
 
Spoilt for Choice: A Survey of Current Practices of Surgical Urinary Stone Treatment and Adherence to Evidence-Based Guidelines among Swiss Urologists.
Betschart P., Zumstein V., Jichlinski P., Herrmann TRW, Knoll T., Engeler D.S., Müllhaupt G., Schmid H.P., Abt D., 2019. Urologia internationalis, 103 (3) pp. 357-363. Peer-reviewed.
 
Changement de pratique en urologie et dans le monde de la santé : les bienfaits de la prise de recul []
Jichlinski P., Iselin C.E., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2147-2148. Peer-reviewed.
 
Chirurgie ambulatoire en urologie : il est temps d’en parler [Ambulatory surgery in urology]
Haverdings H., Vola F., Altwegg G., Chollet M., Jichlinski P., Lucca I., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2164-2166. Peer-reviewed.
 
Réhabilitation améliorée après chirurgie urologique majeure : quel rôle pour le médecin généraliste ? [Improved rehabilitation after major urological surgery : what role for the general practitioner ?]
Martel P., Crettenand F., M'baya O., Cerantola Y., Jichlinski P., Lucca I., 2018/11/28. Revue medicale suisse, 14 (629) pp. 2150-2153. Peer-reviewed.
 
Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy.
Chevalier M.F., Schneider A.K., Cesson V., Dartiguenave F., Lucca I., Jichlinski P., Nardelli-Haefliger D., Derré L., 2018/11. European urology, 74 (5) pp. 540-544. Peer-reviewed.
 
Urologie [Urology]
Jichlinski P., 2018/01/10. Revue medicale suisse, 14 (588-589) pp. 97-99. Peer-reviewed.
Ablation du cancer primaire dans les néoplasies urologiques oligométastatiques : évidence ou vœux pieux ? [Local treatment in oligometastatic urological malignancies : evidence of wishful thinking ?]
Valerio M., Cerantola Y., Lucca I., Berthold D., Jichlinski P., 2017/11/29. Revue medicale suisse, 13 (585) pp. 2083-2086. Peer-reviewed.
Immunothérapie : une révolution dans la prise en charge du cancer de la vessie ? [Immunotherapy : a revolution in the management of urothelial bladder cancer ?]
Adam S.M., Derré L., Jichlinski P., Lucca I., 2017/11/29. Revue medicale suisse, 13 (585) pp. 2074-2078. Peer-reviewed.
 
Urologie évolutive : par X, Y et Z… et encore ! []
Iselin C.E., Jichlinski P., 2017/11/29. Revue medicale suisse, 13 (585) p. 2067. Peer-reviewed.
 
Carcinome urothélial de la vessie et des voies urinaires hautes
Julita Loïc, Jichlinski Patrice, Lucca Ilaria, 2017/08/30. Forum Médical Suisse ‒ Swiss Medical Forum, 17 (35). Peer-reviewed.
Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer.
Chevalier M.F., Bohner P., Pieraerts C., Lhermitte B., Gourmaud J., Nobile A., Rotman S., Cesson V., Martin V., Legris A.S. et al., 2017/06. European urology, 71 (6) pp. 854-857. Peer-reviewed.
 
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.
Derré L., Cesson V., Lucca I., Cerantola Y., Valerio M., Fritschi U., Vlamopoulos Y., Burruni R., Legris A.S., Dartiguenave F. et al., 2017/02/01. Clinical cancer research, 23 (3) pp. 717-725. Peer-reviewed.
Urologie [Urology : therapeutics news in 2016]
Jichlinski P., 2017/01/11. Revue medicale suisse, 13 (544-545) pp. 110-111. Peer-reviewed.
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.
Chevalier M.F., Trabanelli S., Racle J., Salomé B., Cesson V., Gharbi D., Bohner P., Domingos-Pereira S., Dartiguenave F., Fritschi A.S. et al., 2017. The Journal of Clinical Investigation, 127 (8) pp. 2916-2929. Peer-reviewed.
 
Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect.
Jacqmin D., Jichlinski P., Molinier L., de la Taille A., Irani J., Malavaud B., 2017. Urologia internationalis, 99 (3) pp. 358-366. Peer-reviewed.
 
Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.
Domingos-Pereira S., Cesson V., Chevalier M.F., Derré L., Jichlinski P., Nardelli-Haefliger D., 2017. Oncoimmunology, 6 (1) pp. e1265720. Peer-reviewed.
 
Bilan et traitements des infections urogénitales [Assessment and treatment of genitourinary infections]
Martel P., M'Baya O., Senn L., Jichlinski P., Cerantola Y., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2054-2059. Peer-reviewed.
 
Médicaments usuels en médecine de premier recours et cancer de la prostate : quelle relation ? [Common medications and prostate cancer : what is the association ?]
Rakauskas A., Grilo N., M'Baya O., Jichlinski P., Valerio M., Berthold D., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2068-2071. Peer-reviewed.
Prise en charge des traumatismes urogénitaux [Management of genitourinary trauma]
Perrin A., Grilo N., Meuwly J.Y., Jichlinski P., Valerio M., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2072-2076. Peer-reviewed.
Vers une réforme « concertée » de l’incitatif financier dans le système de santé ?
Jichlinski P., Iselin C.E., 2016/11/30. Revue medicale suisse, 12 (541) pp. 2051-2052. Peer-reviewed.
 
Le traitement standard du cancer de la vessie non musculo-invasif avec du BCG peut être associé à une vaccination anti-cancer pour augmenter la réponse vaccinale cellulaire T locale
Jichlinski P., Derré L., Nardell-Haefliger D., Speiser D., Romero P., 2016/11., Société française d'urologie p. 705 dans 110e Congrès français d'urologie, Progrès en Urologie.
 
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis.
Lucca I., Jichlinski P., Shariat S.F., Rouprêt M., Rieken M., Kluth L.A., Rink M., Mathieu R., Mbeutcha A., Maj-Hes A. et al., 2016/04. European urology focus, 2 (1) pp. 79-85. Peer-reviewed.
 
The role of minimally invasive surgery on enhanced recovery after nephrectomy
M'Baya Olivier, Grilo Nuno, Valerio Massimo, Dartiguenave Florence, Puricel Serban, Blanc Catherine, Jichlinski Patrice, Cerantola Yannick, 2016/04. pp. e52 dans Clinical Nutrition ESPEN.
Targeting endothelial connexin40 inhibits tumor growth by reducing angiogenesis and improving vessel perfusion.
Alonso F., Domingos-Pereira S., Le Gal L., Derré L., Meda P., Jichlinski P., Nardelli-Haefliger D., Haefliger J.A., 2016/03/22. Oncotarget, 7 (12) pp. 14015-14028. Peer-reviewed.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
James N.D., Sydes M.R., Clarke N.W., Mason M.D., Dearnaley D.P., Spears M.R., Ritchie A.W., Parker C.C., Russell J.M., Attard G. et al., 2016/03/19. Lancet (London, England), 387 (10024) pp. 1163-1177. Peer-reviewed.
Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.
Hojeij R., Domingos-Pereira S., Nkosi M., Gharbi D., Derré L., Schiller J.T., Jichlinski P., Nardelli-Haefliger D., 2016/03/14. International journal of molecular sciences, 17 (7) pp. E1125. Peer-reviewed.
 
Analyse de l’infiltration immunitaire au cours des instillations intravésicales de BCG : identification d’un profil immunosuppressif prédictif de la récidive tumorale
Chevalier M., Trabanelli S., Gharbi D., Cesson V., Domingos-Pereira S., Dartiguenave F., Fritschi A., Speiser D., Romero P., Jandus C. et al., 2016., Société française d'urologie p. 707 dans 110e Congrès français d'urologie, Progres en urologie .
 
The role of renal biopsy in small renal masses.
Burruni R., Lhermitte B., Cerantola Y., Tawadros T., Meuwly J.Y., Berthold D., Jichlinski P., Valerio M., 2016. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 10 (1-2) pp. E28-33. Peer-reviewed.
 
Biopsies de la prostate en 2015: quelle biopsie pour quel patient [Prostate biopsy: which strategy for which patient?].
Burruni R., Cerantola Y., Meuwly J.Y., Tawadros T., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (497) pp. 2288-90, 2292.
 
Dépistage du cancer de la prostate: partager avec le patient les incertitudes [Sharing uncertainties of prostate cancer screening].
Selby K., Auer R., Valerio M., Jichlinski P., Cornuz J., 2015. Revue Médicale Suisse, 11 (496) pp. 2216, 2218-2216, 2220.
 
High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools.
Chevalier M.F., Bobisse S., Costa-Nunes C., Cesson V., Jichlinski P., Speiser D.E., Harari A., Coukos G., Romero P., Nardelli-Haefliger D. et al., 2015. Oncoimmunology, 4 (10) pp. e1029702. Peer-reviewed.
Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor.
Domingos-Pereira S., Hojeij R., Reggi E., Derré L., Chevalier M.F., Romero P., Jichlinski P., Nardelli-Haefliger D., 2015. Oncoimmunology, 4 (7) pp. e1016697. Peer-reviewed.
 
Urologie [Urology].
Boldini M., Cerantola Y., Jichlinski P., Valerio M., 2015. Revue Médicale Suisse, 11 (456-457) pp. 143-147.
 
Prise en charge des endométriomes et de l'endométriose recto-vaginate et vésicate [Management of endometrioma, recto-vaginal and bladder endometriosis].
Vulliemoz N Complete, Meuwly J Y, Jichlinski P, Hahnloser D, Achtari C, 2014/10. Revue Médicale Suisse, 10 (447) pp. 1977-8, 1980-4. Peer-reviewed.
 
Urologie [Urology]
Jichlinski P., 2014/01/15. Revue medicale suisse, 10 (412-413) pp. 127-129. Peer-reviewed.
 
Comorbidity and nutritional indices as predictors of morbidity after transurethral procedures: A prospective cohort study.
Valerio M., Cerantola Y., Fritschi U., Hubner M., Iglesias K., Legris A.S., Lucca I., Vlamopoulos Y., Vaucher L., Jichlinski P., 2014. Canadian Urological Association Journal, 8 (9-10) pp. E600-E604. Peer-reviewed.
 
Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy?
Patel H.R., Cerantola Y., Valerio M., Persson B., Jichlinski P., Ljungqvist O., Hubner M., Kassouf W., Müller S., Baldini G. et al., 2014. European Urology, 65 (2) pp. 263-266. Peer-reviewed.
 
Fungus ball in the urinary tract: A rare entity.
Praz V., Burruni R., Meid F., Wisard M., Jichlinski P., Tawadros T., 2014. Canadian Urological Association Journal = Journal de l'Association des Urologues du Canada, 8 (1-2) pp. E118-E120.
 
Health technology assessment in evolution - focal therapy in localised prostate cancer.
Valerio M., Emberton M., Barret E., Eberli D., Eggener S.E., Ehdaie B., Jichlinski P., Ward J.F., Ahmed H.U., 2014. Expert Review of Anticancer Therapy, 14 (11) pp. 1359-1367. Peer-reviewed.
Immunotherapeutic strategies for bladder cancer.
Chevalier M.F., Nardelli-Haefliger D., Domingos-Pereira S., Jichlinski P., Derré L., 2014. Human Vaccines and Immunotherapeutics, 10 (4) pp. 977-981. Peer-reviewed.
 
Intravaginal and subcutaneous immunization induced vaccine specific CD8 T cells and tumor regression in the bladder.
Domingos-Pereira S., Derré L., Warpelin-Decrausaz L., Haefliger J.A., Romero P., Jichlinski P., Nardelli-Haefliger D., 2014. Journal of Urology, 191 (3) pp. 814-822.
Low-dose angiostatic tyrosine kinase inhibitors improve photodynamic therapy for cancer: lack of vascular normalization.
Weiss A., van Beijnum J.R., Bonvin D., Jichlinski P., Dyson P.J., Griffioen A.W., Nowak-Sliwinska P., 2014. Journal of Cellular and Molecular Medicine, 18 (3) pp. 480-491. Peer-reviewed.
 
Optical spectroscopy of the bladder washout fluid to optimize fluorescence cystoscopy with Hexvix®.
Martoccia C., Zellweger M., Lovisa B., Jichlinski P., van den Bergh H., Wagnières G., 2014. Journal of Biomedical Optics, 19 (9) p. 97002. Peer-reviewed.
 
Thérapie focale du cancer de la prostate: rationnel, résultats et perspectives [Focal therapy in prostate cancer: rationale, results and perspectives].
Valerio M., Benamran D., Tawadros T., Cerantola Y., Meuwly J.Y., Lutchmaya-Flick C., Lhermitte B., Wirth G., Iselin C., Jichlinski P., 2014. Revue Médicale Suisse, 10 (453) pp. 2306-2310. Peer-reviewed.
 
Are patients at nutritional risk more prone to complications after major urological surgery?
Cerantola Y., Valerio M., Hubner M., Iglesias K., Vaucher L., Jichlinski P., 2013. Journal of Urology, 190 (6) pp. 2126-2132. Peer-reviewed.
 
Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension?
Cerantola Y., Valerio M., Kawkabani Marchini A., Meuwly J.Y., Jichlinski P., 2013. Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada, 7 (11-12) pp. E699-E703. Peer-reviewed.
 
Centre de la prostate: une approche multidisciplinaire pour une prise en charge globale du patient [Prostate cancer center: a multidisciplinary approach to accurately manage patients with prostate cancer]
Tawadros T., Burruni R., Herrera F., Codeluppi C., Zurkinden C., Meuwly J.Y., Lhermitte B., Berthold D., 2013. Revue Médicale Suisse, 9 (409) pp. 2270-2, 2274.
 
Experimental evaluation of an electromechanical artificial urinary sphincter in an animal model.
Valerio M., Jichlinski P., Dahlem R., Tozzi P., Mundy A.R., 2013. BJU International, 112 (4) pp. E337-E343.
 
Guidelines for perioperative care after radical cystectomy for bladder cancer: enhanced Recovery After Surgery (ERAS(®)) society recommendations.
Cerantola Y., Valerio M., Persson B., Jichlinski P., Ljungqvist O., Hubner M., Kassouf W., Muller S., Baldini G., Carli F. et al., 2013. Clinical Nutrition, 32 (6) pp. 879-887. Peer-reviewed.
 
Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non-Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature.
Rink M., Babjuk M., Catto J.W., Jichlinski P., Shariat S.F., Stenzl A., Stepp H., Zaak D., Witjes J.A., 2013. European Urology, 64 (4) pp. 624-638.
Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells.
Decrausaz L., Pythoud C., Domingos-Pereira S., Derré L., Jichlinski P., Nardelli-Haefliger D., 2013. Oncoimmunology, 2 (1) pp. e22944.
Intérêt d'une Consultation spécialisée multidisciplinaire en neuro-urologie et urologie fonctionnelle [Benefit of a specialized multidisciplinary clinic in neuro-urology and functional urology].
Tawadros C., Tawadros T., Julita L., Jichlinski P., Schurch B., 2013. Revue Médicale Suisse, 9 (409) pp. 2286-2288. Peer-reviewed.
 
Photodynamic Diagnosis of Non-muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data.
Burger M., Grossman H.B., Droller M., Schmidbauer J., Hermann G., Drăgoescu O., Ray E., Fradet Y., Karl A., Burgués J.P. et al., 2013. European Urology, 64 (5) pp. 846-854.
 
Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T., Alonso F., Jichlinski P., Clarke N., Calandra T., Haefliger J.A., Roger T., 2013. Endocrine-Related Cancer, 20 (1) pp. 137-149.
Rétablissement postopératoire optimisé, applique aux patients après cystectomie [Enhanced recovery after surgery applied to cystectomy patients].
M'Baya O., Vlamopoulos Y., Hubner M., Blanc C., Jichlinski P., Cerantola Y., 2013. Revue Médicale Suisse, 9 (409) pp. 2279-82, 2284-5. Peer-reviewed.
 
Urologie."Revisitons la prostate!" [Urology. Trends in prostatic diseases in 2012].
Jichlinski P., 2013. Revue Médicale Suisse, 9 (369) pp. 147-149.
 
Hommage au professeur Hans-Jürg Leisinger [Homage to Professor Hans-Jürg Leisinger]
Jichlinski P., Iselin C., 2012/12/05. Revue medicale suisse, 8 (365) pp. 2315-2316. Peer-reviewed.
 
La circoncision: une banalité? [Male circumcision: a banality?]
Wisard M., Jichlinski P., 2012/12/05. Revue medicale suisse, 8 (365) pp. 2324-2326. Peer-reviewed.
 
An unusual phyllodes tumour of the prostate (FP17)
Fontanella S., Fritschi U., Jichlinski P., deLeval L., Rotman S., 2012/11., 78. Annual Meeting of the Swiss Society of Pathology. St. Gallen, Switzerland, 8.-10. November 2012 pp. 575-576 dans Der Pathologe, Springer Medizin.
 
Bladder cancer documentation of causes: multilingual questionnaire, 'bladder cancer doc'
Golka Klaus, Abreu-Villaca Yael, Anbari Attar Rowshanak, Angeli-Greaves Miriam, Aslam Muhammad, Basaran Nursen, Belik Rouslana, Butryee Chaniphun, Dalpiaz Orietta, Dzhusupov Keneshbek et al., 2012. Frontiers in Bioscience (Elite edition), 4 (8) pp. 2809-2822. Peer-reviewed.
Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients.
Pieraerts C., Martin V., Jichlinski P., Nardelli-Haefliger D., Derre L., 2012. Oncoimmunology, 1 (5) pp. 694-698.
Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice.
Domingos-Pereira S., Decrausaz L., Derré L., Bobst M., Romero P., Schiller J.T., Jichlinski P., Nardelli-Haefliger D., 2012. Mucosal Immunology, 6 (2) pp. 393-404.
Percutaneous drainage and sclerotherapy as definitive treatment of renal lymphangiomatosis.
Valerio M., Meuwly J.Y., Tawadros C., Jichlinski P., 2012. Canadian Urological Association Journal = Journal de l'Association des Urologues du Canada, 6 (1) pp. E3-E7.
Urologie [Urology in 2011].
Jichlinski P., 2012. Revue Médicale Suisse, 8 (323) pp. 61-63. Peer-reviewed.
What is the influence of vaccination's routes on the regression of tumors located at mucosal sites?
Nardelli-Haefliger D., Romero P., Jichlinski P., 2012. Oncoimmunology, 1 (2) pp. 242-243.
Testostérone et prostate [Testosterone and prostate]
Vaucher L., Paduch D.A., Jichlinski P., Pralong F., 2011/12/07. Revue medicale suisse, 7 (320) pp. 2399-2400,2402-2403. Peer-reviewed.
Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)
Centre hospitalier universitaire vaudois, Policlinique médicale universitaire (Lausanne) , 2011/05. 2 p..
Mise en place percutanée de filtres dans la veine cave inférieure en prévention de l'embolie pulmonaire : recommandations
Mazzolai L., Qanadli S., 2011/04. 7 p..
 
A murine genital-challenge model is a sensitive measure of protective antibodies against human papillomavirus infection.
Longet S., Schiller J.T., Bobst M., Jichlinski P., Nardelli-Haefliger D., 2011. Journal of Virology, 85 (24) pp. 13253-13259.
 
A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers.
Decrausaz L., Gonçalves A.R., Domingos-Pereira S., Pythoud C., Stehle J.C., Schiller J., Jichlinski P., Nardelli-Haefliger D., 2011. International Journal of Cancer. Journal International Du Cancer, 128 (9) pp. 2105-2113.
 
Animal Tissue Response To Mid-Term Electronic Modular Artificial Sphincter Implantation
Valerio M., Jichlinski P., Dahlem R., Wieland M., Tozzi P., Hayoz D., Mundy A.R., 2011. pp. e39, A92 dans AUA 2011,, Journal of Urology. Peer-reviewed.
 
Combined radiohormonotherapy in node positive lymph node prostate cancer
Herrmann E., Boujelbene N., Ozsahin M., Khanfir K., Mirimanoff R.O., Jichlinski P., Gygi C., Zouhair A., 2011. p. 537 dans 15th Annual Meeting of the Scientific Association of Swiss Radiation Oncology, Strahlentherapie und Onkologie. Peer-reviewed.
 
Contrôle de qualité en urologie [Quality assessment in urology].
Cerantola Y., Jichlinski P., 2011. Revue Médicale Suisse, 7 (320) pp. 2382-2387.
 
Ex vivo ultrasound control of resection margins during partial nephrectomy.
Doerfler A., Cerantola Y., Meuwly J.Y., Lhermitte B., Bensadoun H., Jichlinski P., 2011. Journal of Urology, 186 (6) pp. 2188-2193.
 
Ex-Vivo Ultransonographic Control Of Resection Margin During Partial Nephrectomy
Cerantola Y., Chollet Y., Meuwly J.Y., Jichlinski P., Doerfler A., 2011. pp. 55-56 dans 26th Annual Congress of the European Association of Urology, European Urology Supplements. Peer-reviewed.
 
Ex-vivo ultrasound control of resection margins during partial nephrectomy
Cerantola Y., Doerfler A., Chollet Y., Meuwly J.Y., Jichlinsky P., 2011. pp. S21 dans European School of Oncology Educational Cancer Lugano Convention (ECCLU), Workshop on Whats New and Whats True in Genito-Urinary Oncology, Critical Reviews in Oncology Hematology. Peer-reviewed.
 
High magnification cystoscopy in the primary diagnosis of bladder tumors.
Jichlinski P., Lovisa B., 2011. Current Opinion in Urology, 21 (5) pp. 398-402.
 
Intravaginal TLR Agonists Increase Local Vaccine-Specific CD (T-cells and Human Papillomavirus-Associated Genital-Tumor Regression in Mice
Domingos-Pereira S., Decrausaz L., Derré L., Bobst M., Romero P., Schiller J., Jichlinski P., Nardelli-Haefliger D., 2011. dans Society for Immunotherapy of Cancer SITC 26th Annual Meeting.
 
Intérêt de la tomographie par émission de positons couplée à la scanographie (TEP/TDM) dans les cancers urologiques [Value of positron emission tomography and computer tomography (PET/CT) for urologic malignancies].
Boujelbene N., Prior J.O., Boubaker A., Azria D., Schaffer M., Gez E., Jichlinski P., Meuwly J.Y., Mirimanoff R.O., Ozsahin M. et al., 2011. Cancer Radiothérapie, 15 (4) pp. 307-315.
Metastatic primary adenocarcinoma of the bladder in a twenty-five years old woman.
Valerio M., Lhermitte B., Bauer J., Jichlinski P., 2011. Rare Tumors, 3 (1) pp. e9.
 
Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.
Decrausaz L., Domingos-Pereira S., Duc M., Bobst M., Romero P., Schiller J.T., Jichlinski P., Nardelli-Haefliger D., 2011. International Journal of Cancer. Journal International Du Cancer, 129 (3) pp. 762-772.
 
Prostate normal anatomy and pathologic findings on endorectal coil MRI
Kawkabani Marchini A., Chollet Y., Jichlinski P., Meuli R., Meuwly J.Y., 2011. dans SSR 2011, 98th Annual Meeting of the Swiss Society of Radiology.
 
Split-bolus MDCT urography after diuretic injection in the evaluation of patients with hematuria
Sgourdos G., Saverot A., Nakajo C., Kawkabani Marchini A.., Chollet Y., Jichlinski P., Meuwly J.Y., 2011. dans SSR 2011, 98th Annual Meeting of the Swiss Society of Radiology.
 
Surveillance active du cancer de la prostate [Active surveillance in prostate cancer].
Valerio M., Vaucher L., Cerantola Y., Berthold D., Herrera F.G, Jichlinski P., 2011. Revue Médicale Suisse, 7 (320) pp. 2388-2391. Peer-reviewed.
 
Urinary sphincter based on electronics and artificial muscles
Valerio M., Tozzi P., Wieland M., Hayoz D., Mundy A.R., Jichlinski P., 2011. p. 614 dans 38th Congress of the European Society for Artificial Organs (ESAO 2011) and 4th Biennial Congress of the International Federation on Artificial Organs (IFAO 2011), International Journal of Artificial Organs. Peer-reviewed.
 
Urinary Sphincter Based on Electronics and Artificial Muscles
Valerio M., Tozzi P., Wieland M., Hayoz D., Mundy A.R., Jichlinski P., 2011. dans 38th Congress of the European Society for Artifi cial Organs (ESAO 2011) and 4th Biennial Congress of the International Federation on Artifi cial Organs (IFAO 2011), Clinical Medicine. Life and Biomedical Sciences. Peer-reviewed.
 
Urologie [Urology in 2010].
Jichlinski P., 2011. Revue Médicale Suisse, 7 (277) pp. 80-82.
 
Limites des procédés d'investigation de la fonction érectile dans le cadre d'expertises médicolégales [Limits of the processes of investigation of the erectile function in forensic expertises].
M. Wisard , T. Krompecher , P. Mangin , P. Jichlinski , 2010/03. Revue de médecine légale, 1 (1) pp. 8-12.
 
Apport de l'utltrasonographie dans la chirurgie d'épargne du rein et du testicule [Benefits of ultrasonography in kidney and testicular-sparing surgery].
Cerantola Y., Vaucher L., Doerfler A., Meuwly J.Y., Jichlinski P., 2010. Revue Médicale Suisse, 6 (274) pp. 2365-2368.
 
Artificial Urinary Sphincter based on smart materials
Valerio M., Tozzi P., Wieland M., Conus P-A., Thevenaz P., Mundy A. R., Hayoz D., Jichlinski P., 2010. pp. S105 dans 45th Congress of the European Society for Surgical Research, British Journal of Surgery. Peer-reviewed.
 
Dépistage du cancer de la prostate: utilité, buts et perspectives en 2010 [Prostate cancer screening: utility, goals and perspectives in 2010].
Iselin C., Jichlinski P., 2010. Revue Médicale Suisse, 6 (274) pp. 2336-2339.
 
Fluorescence of the bladder washout fluid following cystoscopy: a preliminary study
Lovisa B., Novello A.M., Jichlinski P., Van den Bergh H., Wagnieres G., 2010. pp. 75481J dans Conference on Photonic Therapeutics and Diagnostics VI, Proceedings of SPIE.
 
Fluoreszenzdiagnostik bei Patienten mit nicht muskelinvasivem Harnblasenkarzinom: Ergebnisse einer Metaanalyse [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis]
Kausch I., Sommerauer M., Montorsi F., Stenzl A., Jacqmin D., Jichlinski P., Jocham D., Ziegler A., Vonthein R., 2010. Aktuelle Urologie, 41 (3) pp. 171-177.
 
High-magnification vascular imaging to reject false-positive sites in situ during Hexvix® fluorescence cystoscopy
Lovisa Blaise, Jichlinski Patrice, Weber Bernd-Claus, Aymon Daniela, van den Bergh Hubert, Wagnières Georges , 2010. Journal of Biomedical Optics, 15 (5) p. 051606. Peer-reviewed.
 
Image en fluorescence en endoscopie: contribution dans la prise en charge des tumeurs de vessie [Fluorescence guided endoscopy: improvement in the management of bladder cancer].
Uffer M., Jichlinski P., 2010. Revue Médicale Suisse, 6 (274) pp. 2352-2354.
 
L'urologue au centre des progrès attendus quant à la prise en charge du cancer localisé de la prostate [The urologist at the center of the expected progress on the management of localized prostate cancer!].
Jichlinski P., Iselin C., 2010. Revue Médicale Suisse, 6 (274) pp. 2331-2332.
Periurethral abscess complicating gonococcal urethritis: case report and literature review.
Kenfak-Foguena A., Zarkik Y., Wisard M., Praz V., Darling K.E., Jaton-Ogay K., Jichlinski P., Cavassini M., 2010. Infection, 38 (6) pp. 497-500.
 
Positron Emission Tomography and Computer Tomography (PET/CT) in Prostate, Bladder, and Testicular Cancers.
Zouhair A., Ozsahin M., Schaffer M., Albrecht S., Camus F., Jichlinski P., Mirimanoff R.O., Delaloye A.B., Meuwly J.Y., Prior J.O., 2010. Current Medicinal Chemistry, 17 (23) pp. 2492-502.
 
R6le de l'urotlogue dans le dépistage des maladies osseuses [Role of the urologist in the screening of bone diseases].
Valerio M., Lamy O., Paduch D.A., Jichlinski P., Vaucher L., 2010. Revue Médicale Suisse, 6 (274) pp. 2340-2345.
Dépistage du cancer de la prostate: actualité [Prostate cancer screening: an update]
Tawadros T., Doerfler A., Treuthardt C., Praz V., Levi F., Zouhair A., Berthold D., Bauer J., Iselin C., Jichlinski P., 2009/12/02. Revue medicale suisse, 5 (228) pp. 2438-2441. Peer-reviewed.
 
L'urologie, une spécialité en mouvement
Iselin C., Jichlinski P., 2009/12. Revue Médicale Suisse, 5 (228) p. 2435.
 
Prise en charge des coliques néphrétiques en urgence [Emergency management of renal colic]
Valerio M., Doerfler A., Chollet Y., Schreyer N., Guyot S., Jichlinski P., 2009/12. Revue Médicale Suisse, 5 (228) pp. 2457-2461.
 
Cryopreservation of prostate cancer tissue during routine processing of fresh unfixed prostatectomy specimen: demonstration and validation of a new technique.
Schäfer S.C., Pfnür M., Yerly S., Fandel T.M., Jichlinski P., Lehr H.A., 2009/02. Prostate, 69 (2) pp. 191-7.
 
Images in clinical urology. Nail of glans penis.
Treuthardt C., Jichlinski P., 2009. Urology, 74 (1) pp. 69-70.
 
Immunothérapie des cancers de la vessie dans des modèles murins: vaccination et administration locale d'immunostimulants : P117
Domingos-Pereira S., Decrausaz L., Bobst M., Jichlinski P., Nardelli-Haefliger D., 2009. dans 65e Assemblée Annuelle de la Société Suisse d'Urologie.
 
Ischemic cecal perforation secondary to ESWL of junctional stone in ureterosigmoidostomy (Mainz Pouch II).
Cardinaux C., Tawadros T., Praz V., Wisard M., Treuthardt C., Jichlinski P., 2009. Urology, 73 (6) pp. 1423.e1-2.
 
La surveillance active dans la prise en charge du cancer de la prostate précoce. [Active surveillance for early-stage prostate cancer]
Jichlinski P., Berthold D. R., Zouhair A., Griesser A. C., Meuwly J. Y., Prior J. O., Lhermitte B., Doerfler A., Treuthardt C., Praz V. et al., 2009. Revue médicale suisse, 5 (228) pp. 2442-4, 2446-7.
 
La thrombose de varicocèle : une étiologie rare de douleur testiculaire [Varicocele thrombosis: a rare etiology of testicular pain]
Doerfler A., Ramadani D., Meuwly J.Y., Jichlinski P., 2009. Progrès en urologie, 19 (5) pp. 351-352. Peer-reviewed.
 
Métastase sus-claviculaire d'un cancer de la prostate : présentation d'un cas : P103
Tawadros C., Doerfler A., Zarkik Y., Chollet Y., Praz V., Jichlinski P., 2009. dans 65e Assemblée Annuelle de la Société Suisse d'Urologie.
 
Nail of the glans penis : P125
Treuthardt Cédric, Jichlinski Patrice, 2009. dans 65e Assemblée Annuelle de la Société Suisse d'Urologie.
 
Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies.
Kausch Ingo, Sommerauer Martin, Montorsi Francesco, Stenzl Arnulf, Jacqmin Didier, Jichlinski Patrice, Jocham Dieter, Ziegler Andreas, Vonthein Reinhard, 2009. European Urology, 57 (4) pp. 595-606.
 
Traitement percutané d'un volumineux lymphangiome périrénal : P91
Tawadros C., Doerfler A., Tawadros T., Treuthardt C., Meuwly J., Jichlinski P., 2009. dans 65e Assemblée Annuelle de la Société Suisse d'Urologie.
 
Urologie [Urology]
Jichlinski P., Wisard M., 2009. Revue Médicale Suisse, 5 (186) pp. 144-146.
 
De la médecine factuelle (evidence-based medicine) au "libre arbitre" [Evidence-based medicine as "free will"]
Jichlinski P., Iselin C., 2008/12. Revue Médicale Suisse, 4 (182) p. 2611.
 
Fractures " fermées" de la verge: à propos de deux cas [Closed "penile" fractures: about two cases]
Wisard M., Aymon D., Meuwly J. Y., Jichlinski P., Praz V., 2008/10. Progrès en Urologie, 18 (9) pp. 617-9. Peer-reviewed.
 
Percutaneous biopsy, a new paradigm for the work-up of small renal masses: review of two years of application in CHUV.
Koehli M., Uffer M., Zarkik Y., Jichlinski P., Denys A., Schnyder P., Meuwly JY., 2008/09. dans SSU 2008 64ème Assemblée Annuelle de la Société Suisse d’Urologie, Davos, Suisse. Abstract.
 
Ultrasound contrast agents for renal investigations: toy or tool?
Kawkabani A., Uffer M., Praz V., Chollet Y., Bize P., Jichlinski P., Schnyder P., Meuwly JY., 2008/09. dans SSU 2008 64ème Assemblée Annuelle de la Société Suisse d'Urologie, Davos, Suisse. Abstract.
 
Un cas rare de douleur testiculaire: la thrombose de varicocèle.
Doerfler A., Ramadani D., Meuwly JY., Jichlinski P., 2008/09. dans SSU 2008 64ème Assemblée Annuelle de la Société Suisse d'Urologie, Davos, Suisse. Abstract.
Fluoreszenzzystoskopie. Perspektiven in Klinik und Forschung [Fluorescence cystoscopy : Perspective in clinical practice and research = Cystoscopie de fluorescence : Perspective clinique et recherche]
Jichlinski P., Lovisa B., Erling C., Aymon D., van den Berg H., Wagnieres G., 2008/08. Urologe A, 47 (8) pp. 975-77. Peer-reviewed.
Management of cryptorchidism in children: guidelines
Gapany C., Frey P., Cachat F., Gudinchet F., Jichlinski P., Meyrat B. J., Ramseyer P., Theintz G., Burnand B., 2008/08. Swiss Medical Weekly, 138 (33-34) pp. 492-498. Peer-reviewed.
 
Photodynamische Diagnostik im Harntrakt. Konsensusempfehlungen des Arbeitskreises Onkologie der Deutschen Gesellschaft fur Urologie [Photodynamic diagnostics in the urinary tract : Consensus paper of the Working Group for Oncology of the German Society for Urology.]
Stenzl A., Jocham D., Jichlinski P., Junker K., Konig F., van den Bergh H., Volkmer B., Zaak D., Gschwend J. E., 2008/08. Urologe A, 47 (8) pp. 982-7. Peer-reviewed.
 
Imaging spectrum of the operatd bladder
Meuwly J.Y., Alamo Maestre L., Jichlinski P., Schnyder P., Gudinchet F., 2008/05. dans SGR-SSR 2008, 95ème Congrès annuel de la Société Suisse de Radiologie, Olma, St-Gall, Switzerland. SMF-FMS Forum médical suisse, p.51. Exposition scientifique SSR. Abdominal. Poster.
 
Imaging spectrum of the solid pseudopapillary tumor of the pancreas.
Al Quatani S., Laswed T., Gudinchet F., Alamo Maestre L., Jichlinski P., Schnyder P., Gudinchet F., 2008/05. dans SGR-SSR 2008, 95ème Congrès annuel de la Société Suisse de Radiologie, Olma, St-Gall, Switzerland. SMF-FMS Forum médical suisse, p.51. Exposition scientifique SSR. Abdominal. Poster.
 
Ultrasound contrast agents for renal investigations: toy or tool?
Kawkabani A., Bize P., Jichlinski P., Schnyder P., Meuwly J.Y., 2008/05., SGR-SSR 2008, 95ème Congrès annuel de la Société Suisse de Radiologie, Olma, St-Gall, Switzerland. Exposition scientifique SSR. Abdominal. Poster. SMF-FMS Forum médical suisse, p.51.
 
Imaging spectrum of the operated bladder : P41
Meuwly J. Y., Alamo Maestre L., Jichlinski P., Schnyder P., Gudinchet F., 2008. pp. 32S dans Swiss Radiological Congress 2008, Swiss Medical Forum = Forum Médical Suisse.
 
Imaging spectrum of the operated bladder: P110
Meuwly JY., Uffer M., Treuthardt C., Alamo Maestre L., Jichlinski P., Schnyder P., Gudinchet F., 2008. p. 75 dans Livre des abstracts de la 64ème Assemblée Annuelle de la Société Suisse d'Urologie.
 
Imaging spectrum of the solid pseudopapillary tumor of the pancreas : P42
Al Quatani S., Laswed T., Alamo Maestre L., Jichlinski P., Schnyder P., Gudinchet F., 2008. pp. 32S dans Swiss Radiological Congress 2008, Swiss Medical Forum = Forum Médical Suisse.
Incontinence urinaire chez la femme: prise en charge en médecine de premier recours [Urinary incontinence in women: management in primary care]
Gonthier A., Pasche O., Achtari C., Jichlinski P., Cornuz J., 2008. Revue Médicale Suisse, 4 (181) pp. 2569-2570, 2572-2574. Peer-reviewed.
 
Increased MIF secretion by neuroendocrine differentiated LNCAP cells induces proliferation and survival of prostate cancer cells
Tawadros T, Roger T, Calandra T, Haefliger J.A, Jichlinski P., 2008. dans Abstract Milan Congress.
 
La néphrectomie partielle dans le cancer du rein: un nouveau standard [Partial nephrectomy in renal cancer: a new standard?]
Doerfler A., Zarkik Y., Chollet Y., Treuthardt C., Praz V., Jichlinski P., 2008. Revue Médicale Suisse, 4 (182) pp. 2629-2630, 2632-2633.
 
Néphrectomie par laparoscopie: aspects techniques [Laparoscopic nephrectomy: technical aspects]
Treuthardt C., Doerfler A., Jichlinski P., 2008. Revue Médicale Suisse, 4 (182) pp. 2636-2640.
 
Percutaneous biopsy, a new paradigm for the work-up of small renal masses : review of two years of application in CHUV
Koehli M, Jichlinski P, Puszlaszeri M, Denys A, Schnyder P, Meuwly J-Y., 2008., Abstract.
 
Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer
Jichlinski Patrice, Jacqmin Didier, 2008. European Urology Supplements, 7 (7) pp. 529-535.
 
Ultrasound Contrast Agents for Renal Investigations: An Emerging Imaging Modality Particularly Well Suited in Cases of Renal Insufficiency : LL-UR1225.
Meuwly JY., Kawkabani A., Bize P., Jichlinski P., Schnyder P., Gudinchet F., 2008. dans RSNA 2008, 94th Scientific Assembly and Annual Meeting.
Urologie [Trends in urology]
Uffer M., Chollet Y., Cardinaux C., Erling C., Praz V., Ramadani D., Tawadros T., Treutherdt C., Wisard M., Zarkik Y. et al., 2008. Revue médicale suisse, 4 (140) pp. 166-8. Peer-reviewed.
 
Well-differentiated papillary mesothelioma of the tunica vaginalis testis: imaging on Tc-99m heat-denatured red blood cell scintigraphy.
Chollet Y., Hauser P., Da Silva T., Meuwly J.Y., Praz V., Jichlinski P., Guillou L., Delaloye A.B., Wisard M., Prior J., 2008. Clinical Nuclear Medicine, 33 (4) pp. 282-284. Peer-reviewed.
 
A case report on idiopathic recurrent priapism.
Wisard M., Aymon D., Jichlinski P., Praz V., 2007/12. Andrologia, 39 (6) pp. 261-262.
 
Indications et méthodes de dérivations urinaires minimales invasives en oncologie [Indications and methods of invasive minimal urinary derivations in oncology].
Praz V., Chollet Y., Jichlinski P., 2007/12. Revue Médicale Suisse, 3 (136) pp. 2788-90, 2792.
 
Robotique et médecine: quel avenir [Robotics and medicine: what's in the future?].
Iselin C., Jichlinski P., 2007/12. Revue Médicale Suisse, 3 (136) p. 2763.
 
Hexyl-aminolevulinate-mediated photodynamic therapy: how to spare normal urothelium. An in vitro approach
Vaucher L., Jichlinski P., Lange N., Ritter-Schenk C., van den Bergh H., Kucera P., 2007/01. Lasers in Surgery and Medicine, 39 (1) pp. 67-75.
 
Syringocèle: à propos d'un cas [Syringocele: a case report]
Wisard M., Praz V., Aymon D., Meuwly J. Y., Jichlinski P., 2007. Progrès en Urologie, 17 (5) pp. 1003-1004. Peer-reviewed.
 
Urologie. [Urology]
Chollet Y., Aymon D., Cardinaux C., Praz V., Tawadros T., Treuthardt C., Vaucher L., Wisard M., Zaman K., Zarkik Y. et al., 2007/01. Revue Médicale Suisse, 3 (94) pp. 168-71.
 
L'urologie, un regard du passé au futur. En hommage au Professeur Hans-Jürg Leisinger [Trends in urology: homage to Professor Hans-Jurg Leisinger]
Jichlinski P., 2006/12/06. Revue medicale suisse, 2 (90) pp. 2771-2772. Peer-reviewed.
 
La lithiase urinaire: histoire et ethique. [Urinary lithiasis: history and ethics]
Jichlinski P., 2006/12. Revue Médicale Suisse, 2 (90) pp. 2800-3.
 
Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14
Felber L. M., Kundig C., Borgono C. A., Chagas J. R., Tasinato A., Jichlinski P., Gygi C. M., Leisinger H. J., Diamandis E. P., Deperthes D. et al., 2006/06. FEBS Journal, 273 (11) pp. 2505-14. Peer-reviewed.
 
An open pharmacokinetic study of hexylaminolevulinate-induced photodiagnosis after intravesical administration
Collaud S., Jichlinski P., Marti A., Aymon D., Gurny R., Lange N., 2006. Drugs in R and D, 7 (3) pp. 173-86.
 
De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin.
Rotman S., Déruaz C., Venetz J.P., Chaubert P., Benhattar J., Meuwly J.Y., Jichlinski P., Guillou L., Moll S., Pascual M. et al., 2006. Human Pathology, 37 (4) pp. 481-487.
 
Hexyl Aminolevulinate in the detection of bladder cancer a viewpoint by Patrice Jichlinski.
Jichlinski P., 2006. Drugs, 66 (4) pp. 579-580. Peer-reviewed.
 
Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells.
Fattah O.M., Cloutier S.M., Kündig C., Felber L.M., Gygi C.M., Jichlinski P., Leisinger H.J., Gauthier E.R., Mach J.P., Deperthes D., 2006. International Journal of Cancer, 119 (10) pp. 2455-2463. Peer-reviewed.
 
Photodynamic applications in superficial bladder cancer: facts and hopes!
Jichlinski P., 2006. Journal of Environmental Pathology, Toxicology and Oncology, 25 (1-2) pp. 441-51.
 
Treatment of penile carcinoma: to cut or not to cut?
Ozsahin M., Jichlinski P., Weber D.C., Azria D., Zimmermann M., Guillou L., Bulling S., Moeckli R., Mirimanoff R.O., Zouhair A., 2006. International Journal of Radiation Oncology, Biology, Physics, 66 (3) pp. 674-679. Peer-reviewed.
Depistage du cancer de la prostate. "Instantane" d'une pratique quotidienne parmi 300 medecins generalistes du canton de Vaud. [Screening of the prostate cancer. "lnstantaneous" of a daily practice among 300 general practitioners of the canton of Vaud]
Praz V., Jichlinski P., Aymon D., Leisinger H. J., 2005/12. Revue Médicale Suisse, 1 (44) pp. 2840-2. Peer-reviewed.
 
Le traitement laser de l'adenome de la prostate: evolution et perspectives en Suisse romande. [Laser treatment of BPH: evolution and perspectives in the French part of Switzerland]
Jichlinski P., Iselin C., Leisinger H. J., 2005/12. Revue Médicale Suisse, 1 (44) pp. 2854-6.
Recidive biochimique apres traitement a visee curative d'un cancer localise de la prostate. [Biochemical failure after curative treatment for localized prostate cancer]
Zouhair A., Jichlinski P., Mirimanoff R. O., 2005/12. Revue Médicale Suisse, 1 (44) pp. 2844-6, 2848. Peer-reviewed.
 
Enzymatic profiling of human kallikrein 14 using phage-display substrate technology
Felber L. M., Borgono C. A., Cloutier S. M., Kundig C., Kishi T., Ribeiro Chagas J., Jichlinski P., Gygi C. M., Leisinger H. J., Diamandis E. P. et al., 2005/03. Biological Chemistry, 386 (3) pp. 291-8. Peer-reviewed.
 
Applications de la photothérapie dynamique autres que la dermatologie
Mordon S., Maunoury V., Rochon P., Desmettre T., Collinet P., Regis C., Jichlinski P., 2005. Nouvelles Dermatologiques, 24 (Suppl. 5) pp. 42-45.
 
Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist!
Jichlinski P., Leisinger H. J., 2005. Urologia Internationalis, 74 (2) pp. 97-101. Peer-reviewed.
 
Urological complications in renal transplantation from cadaveric donor grafts: a retrospective analysis of 20 years.
Praz V., Leisinger H.J., Pascual M., Jichlinski P., 2005. Urologia internationalis, 75 (2) pp. 144-9. Peer-reviewed.
 
Traitement urologique de la lithiase. [Urologic treatment of lithiasis]
Meid F., Leisinger H. J., Jichlinski P., 2004/08. Revue Médicale de la Suisse Romande, 124 (8) pp. 497-501.
 
Evaluation of the CFP-substrate-YFP system for protease studies: advantages and limitations.
Felber L.M., Cloutier S.M., Kündig C., Kishi T., Brossard V., Jichlinski P., Leisinger H.J., Deperthes D., 2004/05. BioTechniques, 36 (5) pp. 878-885. Peer-reviewed.
 
Profiling of proteolytic activities secreted by cancer cells using phage display substrate technology
Cloutier S. M., Kundig C., Gygi C. M., Jichlinski P., Leisinger H. J., Deperthes D., 2004/04. Tumour Biology, 25 (1-2) pp. 24-30. Peer-reviewed.
 
Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates
Cloutier S. M., Kundig C., Felber L. M., Fattah O. M., Chagas J. R., Gygi C. M., Jichlinski P., Leisinger H. J., Deperthes D., 2004/02. European Journal of Biochemistry, 271 (3) pp. 607-13. Peer-reviewed.
 
Acquisitions thérapeutiques
Wisard M., Marti A., Kellou K., Jichlinski P., Leiisnger H. J., 2004. Médecine et Hygiène, 62 pp. 64-66.
 
Apport de la cystoscopie de la fluorescence dans la prise en charge du cancer de la vessie
Jichlinski P., Leisinger H. J., 2004. Médecine et Hygiène, 62 (2507) pp. 2413-2416.
 
Diversité en urologie
Iselin C., Jichlinski P., 2004. Médecine et Hygiène, 62 (2395).
 
L'infarctus rénal : une pathologie rare
Vaucher L., Leisinger H. J., Jichlinski P., 2004. Médecine et Hygiène, 62 (2507) pp. 2424-2426.
 
La gynécomastie sous-antiandrogènes : un mal ineluctable ? La radiothérapie : un solution simple et efficace
Coucke P. A., Jichlinski P., Matzinger O., Ozsahin M., bulling S., Zouhair A., 2004. Revue Médicale de la Suisse Romande, 124 (1) pp. 51-54.
 
Lithiase cystinique [Cysteine lithiasis].
Barbey F., Cachat F., Gauthier T., Meid F., Jichlinski P., Daudons M., 2004. Revue Médicale de la Suisse Romande, 124 (8) pp. 471-475.
 
Lithiase urinaire [Urinary calculi].
Barbey F., Cachat F., Jichlinski P., Burnier M., 2004. Revue Médicale de la Suisse Romande, 124 (8) p. 432.
 
Lithiases d'infection [Infective lithiasis].
Barbey F., Cachat F., Halabi G., Jichlinski P., Daudon M., 2004. Revue Médicale de la Suisse Romande, 124 (8) pp. 465-469.
 
PDT of bladder carcinoma : the old and the new
Jichlinski P., 2004. Spie, 5312 pp. 65-74.
 
New diagnostic strategies in the detection and staging of bladder cancer.
Jichlinski P., 2003/09. Current Opinion in Urology, 13 (5) pp. 351-355. Peer-reviewed.
 
Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study
Jichlinski P., Guillou L., Karlsen S. J., Malmstrom P. U., Jocham D., Brennhovd B., Johansson E., Gartner T., Lange N., van den Bergh H. et al., 2003/07. Journal of Urology, 170 (1) pp. 226-9. Peer-reviewed.
 
Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A., Jichlinski P., Lange N., Ballini J.P., Guillou L., Leisinger H.J., Kucera P., 2003. The Journal of urology, 170 (2 Pt 1) pp. 428-32. Peer-reviewed.
 
Dans le cadre de votre check-up annuel, désirez-vous que l'on vous dose le PSA ?
Jichlinski P., Leisinger H. J., 2003. Médecine et Hygiène, 61 (Editorial) p. 2371.
 
L'antigène spécifique de la prostate (PSA) : un marqueur tumoral en fin de règne
Deperthes D., Gygi C. M., Jichlinski P., Leisinger H. J., 2003. Médecine et Hygiène, 61 (2461) pp. 2377-2381.
 
La prostatectomie radicale
Iselin C., Jichlinski P., Rohner S., Schmidlin F. R., 2003. Médecine et Hygiène, 61 (2461) pp. 2382-2385.
 
Le cancer de la prostate et l'homme vieillissant
Jichlinski P., Iselin C., Leisinger H. J., 2003. Médecine et Hygiène, 61 (2461) pp. 2374-2376.
 
On the influence of the instillation time on the results of HAL (Hexvix®) fluorescence detection of superficial bladder cancer
Jichlinski P., Aymon D., Wagnières G., Marti A., Lange N., Guillou L., Leisinger H. J., van den Bergh, 2003. Proc SPIES, 5141 pp. 272-277.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University